Related Experiment Video For catecholamine-induced cardiomyopathy
Updated: Mar 27, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Catecholamine-Induced Cardiomyopathy Initially Misdiagnosed as Myocarditis in a Patient With Pheochromocytoma
1Department of Cardiovascular Medicine, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; Cardiovascular Disease Laboratory, Chongqing Medical University, Chongqing, China.
Background:
Catecholamine-induced cardiomyopathy (CICMP) is myocardial injury from excessive catecholamine secretion by pheochromocytoma/paraganglioma (PPGL), with reversible cardiac dysfunction post-tumor resection.
Case Summary:
A 29-year-old female initially hospitalized for severe myocarditis recovered but presented 3 years later with marked blood pressure fluctuations. She was diagnosed with CICMP secondary to pheochromocytoma and managed with aggressive blood pressure control and successful tumor resection, achieving favorable outcomes with stable blood pressure off medications.
Discussion:
Literature review shows CICMP is occult. The reminder for clinicians from this case is that for atypical myocarditis, especially in patients experiencing blood pressure fluctuations, PPGL should be considered, and relevant examinations should be promptly completed.
Take-Home Message:
Blood pressure lability in a young patient with suspected myocarditis should immediately raise suspicion for PPGL and prompt biochemical screening.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis III: Medical Management

